查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1976644

颈椎全椎间盘置换器械市场：依器械类型、手术入路、病患年龄层、最终用户和通路划分－2026-2032年全球预测

Cervical Total Disc Replacement Devices Market by Device Type, Surgery Approach, Patient Age Group, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，整个颈椎间盘置换装置市场价值将达到 4.5149 亿美元，到 2026 年将成长至 4.9146 亿美元，到 2032 年将达到 7.7503 亿美元，复合年增长率为 8.02%。

主要市场统计数据
基准年 2025 4.5149亿美元
预计年份：2026年 4.9146亿美元
预测年份 2032 7.7503亿美元
复合年增长率 (%) 8.02%

从策略角度解释临床需求、相关人员期望和监管趋势的融合，这些融合塑造了全颈全人工椎间盘置换术的决策过程。

由于技术进步、临床指南的不断改进以及对患者长期疗效日益增长的关注，颈椎置换术领域正经历着一段谨慎的转型期。外科医生和医疗设备研发人员致力于改进设计，以平衡可动性支撑和植入耐用性；同时，保险公司和医疗机构也越来越要求提供功能有效性和成本效益的明确证据。此外，患者期望和人口结构的变化也推动着该行业朝着更精细的适应症和治疗路径划分发展。

我们将探索基于证据的技术、临床实践和医疗保健服务的创新，这些创新将重塑颈椎人工全人工椎间盘置换术的实践和市场动态。

近年来，全颈椎间盘置换术的研究、製造和临床应用方式发生了一系列变革性变化。生物材料和表面工程技术的进步有望提高器械的耐用性并降低骨溶解的风险，而新型混合结构旨在平衡融合的稳定性与全人工椎间盘置换术的可动性支撑效果。同时，手术全期通讯协定的完善和復健促进通讯协定的改进正在缩短住院时间并提高病患诊疗效率。这些变化正在对医疗机构的经济效益和诊疗流程产生影响。

对 2025 年实施的新收费系统如何重组全颈全人工椎间盘置换术所有相关人员的采购、定价和供应连续性进行详细评估。

2025年实施的新关税措施将对颈椎人工全人工椎间盘置换术供应链的经济和营运产生重大影响，促使製造商和供应商重新评估其采购和定价策略。零件和成品进口成本的增加推动了尽可能实现本地化生产，加速了供应商多元化，并促使企业重新设计采购合同，以在相关人员之间合理分配风险。因此，采购部门越来越关注供应商合格、近岸外包的可行性以及包含与关税体系和外汇波动挂钩的价格调整机制的长期供应合约。

将终端用户环境、设备结构、手术方法、通路和患者年龄组与可操作的采用驱动因素联繫起来的综合細項分析。

细分市场分析揭示了不同医疗机构、设备结构、手术技术、通路和患者年龄组之间存在不同的部署模式，这些因素共同指南临床策略和商业性优先顺序的发展。在考虑最终用户时，市场分析分为门诊手术中心、医院和专科诊所。门诊手术中心进一步细分为医院所有和独立运营，医院分为私立和公立，私立医院又分为营利性和非营利性。这种细分突显了医疗服务场所的经济状况和所有权结构如何影响设备选择、手术量和服务项目的投资。例如，独立营运的门诊中心倾向于优先选择具有高效处理能力和可预测耗材成本的植入，而公立医院则倾向于优先考虑长期耐用性和广泛的临床应用。

区域比较分析解释了法规环境、支付方需求和医疗保健服务模式如何推动美洲、欧洲、中东和非洲以及亚太地区的差异化策略。

区域趋势对监管策略、临床实务模式和商业性实施都产生深远影响，要求企业根据各司法管辖区的具体情况调整策略。在美洲，临床医生和支付方通常强调成本效益、支付方对比较性临床证据的要求，以及在医院和门诊环境中进行的手术量。该地区的报销环境倾向于鼓励能够缩短恢復时间和降低长期后续成本的创新，尤其关注那些能够促进更快功能恢復并拥有可靠的上市后资料收集的医疗器材。

一份精闢的竞争分析报告，揭示了製造商、供应商和分销合作伙伴如何协调创新、营运和商业模式，以确保可持续的竞争优势。

颈椎人工全人工椎间盘置换术市场的竞争格局呈现出多元化的特点，既有成熟的整形外科和脊椎器械原始设备製造商 (OEM)，也有专业的植入研发公司、精密零件供应商以及服务型经销商。领先的器材研发公司不断投入研发，持续改进植入的运动学、固定功能和材料科学，旨在降低再次手术的风险并拓展适应症。零件供应商则透过提供高精度加工、先进涂层和聚合物配方来解决磨损和生物相容性方面的问题。同时，契约製造也越来越多地提供端到端的解决方案，包括组装和法规文件支援。

作为切实可行的、优先考虑的策略措施，我们建议收集证据、重新设计供应链和保持商业性一致性，以促进采用并维持获利能力。

产业领导者应采取多管齐下的策略，整合临床证据产生、价值链韧性和商业性柔软性，以获得临床应用和营运价值。首先，应优先投资于可操作的临床研究和註册登记，以产生与功能恢復和再次手术率相关的真实世界临床数据，并促进与支付方的对话以及指南的发布。其次，应重新设计筹资策略，透过选择区域供应商、模组化组件以及协商平衡营运资金和供应连续性的库存水平，来降低关税和前置作业时间风险。

透过结合对临床医生的访谈、采购方面的见解和二次检验，我们利用高度透明的混合调查方法框架来产生可重复和可操作的见解。

本研究途径结合了结构化的初步研究和严谨的二次检验，以确保证据基础的平衡性和可重复性。主要研究对象包括脊椎外科医师、医院和门诊中心采购经理、监管专家以及高级商业管理人员的深入访谈，并辅以临床医生问卷调查，以了解手术偏好、材料考量和临床地点限制。这些定性研究结果与同行评审的临床文献、医疗设备註册资料、监管申报文件和公立医院采购文件等二级资讯来源进行三角验证，以检验观察到的趋势并识别证据缺口。

一份权威的综合分析报告，重点阐述了将临床创新、监管严格性和供应链韧性转化为永续产业优势所需的统一优先事项。

总之，全颈椎间盘置换术正处于一个转折点，材料创新、手术流程改进和循证商业化正在融合，为改善患者预后和实现差异化产品定位创造了重要机会。将器械研发与可靠的真实世界临床数据、灵活的供应链结构和客製化的商业策略相结合的相关人员，将更有能力应对复杂的监管环境和支付方的期望。此外，由于区域差异和关税，采购压力不断增加，凸显了适应性生产和在地化合作对于维持医疗服务可近性和控製成本动态的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 颈椎全椎间盘置换器材市场：依器械类型划分

  • 杂交种
  • 金属与金属
    • 钴铬合金
    • 钛合金
  • 金属与聚乙烯
    • 交联聚乙烯
    • 超高分子量聚乙烯

第九章：以手术方式分類的颈椎全椎间盘置换装置市场

  • 前进方向
  • 侧
  • 后方进场

第十章：依病患年龄组别分類的颈椎全盘置换装置市场

  • 31-45岁
  • 46-60岁
  • 60岁或以上
  • 30岁以下

第十一章 颈椎全椎间盘置换装置市场：依最终用户划分

  • 门诊手术中心
    • 医院所有
    • 独立
  • 医院
    • 私人的
      • 以营利为目的
      • 非营利组织
    • 民众
  • 专科诊所

第十二章 颈椎全椎间盘置换装置市场：依通路划分

  • 直接竞标
  • 线上销售
  • 第三方经销商
    • 全国批发商
    • 当地批发商

第十三章 颈椎全椎间盘置换装置市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 颈椎全椎间盘置换装置市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 颈椎全椎间盘置换装置市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国颈椎全盘置换装置市场

第十七章 中国颈椎全椎间盘置换装置市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Aditus Medical GmbH
  • Aesculap, Inc. by B. Braun of America Inc.
  • AxioMed LLC
  • Camber Spine, LLC
  • Centinel Spine, LLC
  • DePuy Synthes, Inc.
  • FH Orthopaedics SAS by Olympus Corporation
  • Globus Medical, Inc.
  • KISCO International Inc.
  • Medacta International
  • Medtronic Plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Orthofix Medical Inc.
  • Spine Innovations
  • Stryker Corporation
  • SYNERGY SPINE SOLUTIONS INC.
  • Zimmer Biomet Holdings, Inc.
  • ZimVie Inc.
Product Code: MRR-69324464D1AB

The Cervical Total Disc Replacement Devices Market was valued at USD 451.49 million in 2025 and is projected to grow to USD 491.46 million in 2026, with a CAGR of 8.02%, reaching USD 775.03 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 451.49 million
Estimated Year [2026] USD 491.46 million
Forecast Year [2032] USD 775.03 million
CAGR (%) 8.02%

A strategic orientation describing the converging clinical imperatives, stakeholder expectations, and regulatory dynamics shaping cervical total disc replacement decision-making

The cervical spine replacement landscape has entered a phase of measured transformation driven by technological evolution, shifting clinical guidelines, and heightened attention to long-term patient outcomes. Surgeons and device developers are converging on design improvements that seek to balance motion preservation with implant durability, while payers and providers increasingly demand clear evidence of functional benefit and cost-effectiveness. At the same time, patient expectations and demographic shifts are nudging the industry toward finer-grained segmentation of indications and care pathways.

Against this backdrop, stakeholders must reconcile competing priorities: minimizing perioperative morbidity, optimizing rehabilitation timelines, and addressing concerns around implant materials and wear. Regulatory pathways remain rigorous, emphasizing robust clinical evidence and post-market surveillance. Consequently, strategic decisions by manufacturers, health systems, and payers hinge on an integrated understanding of clinical performance, supply chain resilience, and reimbursement dynamics. This introduction frames the essential clinical and commercial vectors that will shape device development, adoption, and service delivery in the near term and sets the stage for the deeper analyses that follow.

An evidence-based exploration of the technological, clinical, and care-delivery innovations that are reshaping cervical total disc replacement practice and market dynamics

Recent years have seen a series of transformative shifts that are recalibrating how cervical total disc replacement is researched, manufactured, and delivered in clinical practice. Advances in biomaterials and surface engineering are expanding device longevity prospects and reducing osteolysis risk, while novel hybrid constructs aim to combine the stability of fusion with the motion-preserving benefits of disc replacement. Concurrently, the maturation of perioperative protocols and enhanced recovery pathways is reducing length of stay and streamlining patient throughput, which in turn affects site-of-care economics and procedural workflows.

Moreover, digital health tools and imaging innovations are enhancing preoperative planning and intraoperative accuracy, enabling more patient-specific implant selection and positioning. These technological advances are complemented by a growing emphasis on real-world evidence and registries that inform comparative effectiveness and safety monitoring. Policy changes and reimbursement reform in multiple jurisdictions are also exerting influence, prompting device developers to prioritize evidence packages that demonstrate value across diverse payer environments. Taken together, these shifts are producing a more competitive and evidence-driven market where clinical differentiation, supply chain agility, and outcome transparency determine long-term success.

A detailed assessment of how 2025 tariff implementations have reconfigured sourcing, pricing, and supply continuity considerations across cervical total disc replacement stakeholders

The implementation of new tariff measures introduced in 2025 has had a material effect on the economics and operations of cervical total disc replacement supply chains, prompting manufacturers and providers to reassess sourcing and pricing strategies. Increased import costs for components and finished devices have created incentives to localize manufacturing where feasible, accelerate supplier diversification, and redesign procurement contracts to better allocate risk across stakeholders. As a result, procurement teams are placing greater emphasis on supplier qualification, nearshoring feasibility, and long-term supply agreements that include price adjustment mechanisms tied to tariff regimes and exchange rate volatility.

Clinically, the tariffs have encouraged device makers to prioritize modularity and standardized subassemblies that can be produced or sourced regionally to mitigate cross-border cost exposure. In parallel, hospitals and ambulatory surgical centers have intensified negotiations with manufacturers to secure predictable pricing and value-based contracting arrangements that offset tariff-driven cost inflation. Regulatory and logistics teams have had to account for increased administrative complexity, including documentation for customs and compliance with local content rules, which can extend lead times and inventory planning horizons. Consequently, organizations that proactively adapt their sourcing strategies and contractual frameworks are better positioned to preserve margins and maintain continuity of supply.

An integrative segmentation synthesis linking end user settings, device architectures, surgical approaches, distribution channels, and patient age cohorts to practical adoption levers

Segmentation analysis reveals nuanced adoption patterns across care settings, device architectures, surgical approaches, distribution pathways, and patient age cohorts that collectively inform clinical strategy and commercial prioritization. When considering end users, the market is studied across Ambulatory Surgical Center, Hospital, and Specialty Clinic; the Ambulatory Surgical Center is further studied across Hospital Owned and Independent; the Hospital is further studied across Private and Public; the Private is further studied across For Profit and Non Profit. This granularity highlights how site-of-care economics and ownership models affect device selection, procedure volumes, and service-line investment. For example, independent ambulatory centers often prioritize implants that enable efficient throughput and predictable disposables, while public hospitals may emphasize long-term durability and broader clinical indications.

From a device type perspective, the market is studied across Hybrid, Metal On Metal, and Metal On Polyethylene; the Metal On Metal is further studied across Cobalt Chromium and Titanium Alloy; the Metal On Polyethylene is further studied across Cross Linked Polyethylene and UHMWPE. These distinctions matter for material performance, regulatory considerations, and surgeon preference, as each material set brings different profiles for wear, biocompatibility, and manufacturing complexity. Regarding surgical approach, the market is studied across Anterior, Lateral, and Posterior, and these choices influence implant geometry, fixation strategies, and perioperative risk profiles. Distribution channel segmentation examines Direct Tenders, Online Sales, and Third Party Distributors; the Third Party Distributors are further studied across National Distributors and Regional Distributors, with distribution strategy shaping commercial margins, inventory policies, and service levels. Finally, patient age cohorts are considered across 31 To 45 Years, 46 To 60 Years, Above 60 Years, and Under 30 Years, which informs indication development, patient counseling, and long-term follow-up planning since age correlates with activity level, comorbidity burden, and implant longevity expectations. Integrating these segmentation lenses supports more precise targeting of clinical evidence, commercial models, and post-market surveillance architectures.

A comparative regional analysis describing how regulatory environments, payer demands, and healthcare delivery models drive differentiated strategies across the Americas, EMEA, and Asia-Pacific

Regional dynamics exert a profound influence on regulatory strategy, clinical practice patterns, and commercial execution, requiring companies to tailor their approaches to each jurisdictional reality. In the Americas, clinicians and payers frequently emphasize cost-effectiveness, payer requirements for comparative clinical evidence, and a strong procedural volume base in both hospitals and ambulatory care settings. This region's reimbursement environment often incentivizes innovations that demonstrably shorten recovery times and reduce long-term downstream costs, leading to particular interest in devices that support rapid return-to-function and robust post-market data collection.

In Europe, Middle East & Africa, heterogeneous regulatory pathways and diverse payer models demand flexible go-to-market strategies, with many health systems prioritizing long-term safety records and interoperability with existing surgical platforms. Manufacturers operating across this region must navigate varying national procurement rules and public tender processes while supporting country-specific clinical adoption programs. In the Asia-Pacific region, rapid hospital modernization, a growing middle-class patient population, and expanding surgical capacity are accelerating demand for advanced spine technologies. Local manufacturing and regulatory localization are increasingly strategic priorities here, given cost sensitivity and the emergence of regional centers of excellence that influence neighboring markets. Across all regions, collaborative partnerships with clinical opinion leaders and targeted registries are essential to build local evidence and facilitate guideline integration.

An incisive view of competitive dynamics showing how manufacturers, suppliers, and distribution partners are aligning innovations, operations, and commercial models for sustained advantage

Competitive dynamics in cervical total disc replacement are defined by a mix of established orthopedic and spine device original equipment manufacturers, specialized implant innovators, precision component suppliers, and service-oriented distributors. Leading device developers continue to invest in iterative improvements to implant kinematics, fixation features, and material science to reduce revision risk and expand appropriate indications. Component suppliers are responding by offering higher-tolerance machining, advanced coatings, and polymer formulations that address wear and biocompatibility concerns, while contract manufacturers are increasingly providing end-to-end solutions including assembly and regulatory documentation support.

At the commercial interface, distributors and hospital procurement groups are collaborating more closely with manufacturers to implement managed entry agreements and evidence-based contracting that aligns payment with patient outcomes. Strategic partnerships between device companies and digital health firms are also becoming more common, producing integrated solutions that combine implant technologies with monitoring tools and outcome analytics. These cross-functional collaborations are reshaping value propositions, enabling companies to offer not just implants but comprehensive care pathways that address preoperative optimization, surgical precision, and long-term follow-up. Organizations that align R&D, regulatory planning, and commercial execution around demonstrable clinical value are most likely to sustain competitive advantage.

A pragmatic and prioritized set of strategic moves recommending evidence generation, supply chain redesign, and commercial alignment to accelerate adoption and preserve margin

Industry leaders should adopt a multifaceted strategy that aligns clinical evidence generation, supply chain resilience, and commercial flexibility to capture clinical adoption and operational value. First, prioritize investment in pragmatic clinical studies and registry participation that produce real-world outcomes data linked to functional recovery and reoperation rates, thereby strengthening payer dialogues and guideline inclusion. Second, redesign sourcing strategies to reduce tariff exposure and lead-time risk by qualifying regional suppliers, modularizing components, and negotiating inventory commitments that balance working capital with continuity of supply.

Third, tailor product portfolios and go-to-market models to site-of-care characteristics and ownership structures, ensuring that device offerings and service bundles meet the operational tempo of ambulatory surgical centers as well as the durability demands of large hospital systems. Fourth, pursue cross-sector partnerships that integrate digital monitoring and outcomes analytics to enhance post-market surveillance and support value-based contracting. Finally, embed regulatory foresight into product development timelines so that material choices, design controls, and post-market study plans anticipate regional regulatory expectations, enabling faster market access and smoother commercial scale-up. Taken together, these actions will enable organizations to convert technological advances into sustained clinical and commercial success.

A transparent mixed-methods research framework combining clinician interviews, procurement insights, and secondary validation to produce reproducible and actionable findings

The research approach combines structured primary research with rigorous secondary validation to ensure a balanced and reproducible evidence base. Primary inputs include in-depth interviews with spine surgeons, procurement leaders across hospitals and ambulatory centers, regulatory specialists, and senior commercial executives, complemented by clinician surveys designed to capture procedural preferences, material considerations, and site-of-care constraints. These qualitative insights are triangulated with secondary sources such as peer-reviewed clinical literature, device registries, regulatory filings, and public hospital procurement documents to validate observed trends and identify evidence gaps.

Analytical rigor is maintained through data triangulation, cross-validation of stakeholder perspectives, and sensitivity checks that examine alternative interpretations of qualitative signals. Segmentation frameworks are constructed from clinic-level behavior and payer interactions to ensure that device design, distribution, and clinical adoption assumptions reflect real-world decision drivers. Finally, findings are peer-reviewed by an advisory panel of clinical and industry experts and subjected to methodological transparency disclosures so that assumptions, interview protocols, and inclusion criteria are clearly documented and replicable.

A conclusive synthesis highlighting the integrated priorities required to translate clinical innovation, regulatory rigor, and supply chain resilience into durable industry advantage

In summary, cervical total disc replacement stands at an inflection point where material innovation, procedural refinement, and evidence-driven commercialization converge to create meaningful opportunities for improved patient outcomes and differentiated product positioning. Stakeholders who align device development with robust real-world evidence, flexible supply chain architectures, and tailored commercial strategies will be best positioned to navigate regulatory complexities and payer expectations. Moreover, regional nuances and tariff-induced sourcing pressures underscore the importance of adaptive manufacturing and localized engagement to preserve access and manage cost dynamics.

Looking ahead, sustained success will depend on an integrated approach that unites clinical validation, operational resilience, and value-based commercial models. By prioritizing transparent outcome measurement, strategic partnerships, and proactive regulatory planning, organizations can translate emerging technological advances into durable clinical benefit and measurable health system value. This conclusion synthesizes the core insights and points the way toward deliberate actions that translate analysis into operational priorities and strategic investments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cervical Total Disc Replacement Devices Market, by Device Type

  • 8.1. Hybrid
  • 8.2. Metal On Metal
    • 8.2.1. Cobalt Chromium
    • 8.2.2. Titanium Alloy
  • 8.3. Metal On Polyethylene
    • 8.3.1. Cross Linked Polyethylene
    • 8.3.2. UHMWPE

9. Cervical Total Disc Replacement Devices Market, by Surgery Approach

  • 9.1. Anterior
  • 9.2. Lateral
  • 9.3. Posterior

10. Cervical Total Disc Replacement Devices Market, by Patient Age Group

  • 10.1. 31 To 45 Years
  • 10.2. 46 To 60 Years
  • 10.3. Above 60 Years
  • 10.4. Under 30 Years

11. Cervical Total Disc Replacement Devices Market, by End User

  • 11.1. Ambulatory Surgical Center
    • 11.1.1. Hospital Owned
    • 11.1.2. Independent
  • 11.2. Hospital
    • 11.2.1. Private
      • 11.2.1.1. For Profit
      • 11.2.1.2. Non Profit
    • 11.2.2. Public
  • 11.3. Specialty Clinic

12. Cervical Total Disc Replacement Devices Market, by Distribution Channel

  • 12.1. Direct Tenders
  • 12.2. Online Sales
  • 12.3. Third Party Distributors
    • 12.3.1. National Distributors
    • 12.3.2. Regional Distributors

13. Cervical Total Disc Replacement Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cervical Total Disc Replacement Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cervical Total Disc Replacement Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Cervical Total Disc Replacement Devices Market

17. China Cervical Total Disc Replacement Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Aditus Medical GmbH
  • 18.6. Aesculap, Inc. by B. Braun of America Inc.
  • 18.7. AxioMed LLC
  • 18.8. Camber Spine, LLC
  • 18.9. Centinel Spine, LLC
  • 18.10. DePuy Synthes, Inc.
  • 18.11. FH Orthopaedics S. A. S. by Olympus Corporation
  • 18.12. Globus Medical, Inc.
  • 18.13. KISCO International Inc.
  • 18.14. Medacta International
  • 18.15. Medtronic Plc
  • 18.16. NuVasive, Inc.
  • 18.17. Orthofix Medical Inc.
  • 18.18. Orthofix Medical Inc.
  • 18.19. Spine Innovations
  • 18.20. Stryker Corporation
  • 18.21. SYNERGY SPINE SOLUTIONS INC.
  • 18.22. Zimmer Biomet Holdings, Inc.
  • 18.23. ZimVie Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY TITANIUM ALLOY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY TITANIUM ALLOY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY TITANIUM ALLOY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY CROSS LINKED POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY CROSS LINKED POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY CROSS LINKED POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY UHMWPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY UHMWPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY UHMWPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY ANTERIOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY ANTERIOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY ANTERIOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY LATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY LATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY LATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY POSTERIOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY POSTERIOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY POSTERIOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY 31 TO 45 YEARS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY 31 TO 45 YEARS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY 31 TO 45 YEARS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY 46 TO 60 YEARS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY 46 TO 60 YEARS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY 46 TO 60 YEARS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY ABOVE 60 YEARS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY ABOVE 60 YEARS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY ABOVE 60 YEARS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY UNDER 30 YEARS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY UNDER 30 YEARS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY UNDER 30 YEARS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY FOR PROFIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY FOR PROFIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY FOR PROFIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY NON PROFIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY NON PROFIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY NON PROFIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DIRECT TENDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DIRECT TENDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DIRECT TENDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 207. GCC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GCC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 210. GCC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 212. GCC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. GCC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. GCC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 215. GCC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 216. GCC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 217. GCC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. GCC CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 243. G7 CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. G7 CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 246. G7 CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 248. G7 CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. G7 CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. G7 CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 251. G7 CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 252. G7 CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 253. G7 CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. G7 CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 255. NATO CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. NATO CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. NATO CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 258. NATO CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 259. NATO CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 260. NATO CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 261. NATO CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. NATO CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 263. NATO CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 264. NATO CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PRIVATE, 2018-2032 (USD MILLION)
  • TABLE 265. NATO CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 266. NATO CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES CERVICAL TOTAL DISC REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES CER